799
Participants
Start Date
December 31, 2000
Primary Completion Date
April 30, 2004
Study Completion Date
April 30, 2012
Adalimumab
Methotrexate
Adalimumab placebo
Methotrexate placebo
Site Reference ID/Investigator# 334, Lausanne
Site Reference ID/Investigator# 753, Brussels
Site Reference ID/Investigator# 344, Vienna
Site Reference ID/Investigator# 308, Brussels
Site Reference ID/Investigator# 752, Brussels
Site Reference ID/Investigator# 331, Darlinghurst, Sydney
Site Reference ID/Investigator# 755, Camperdown
Site Reference ID/Investigator# 745, Kogarah
Site Reference ID/Investigator# 335, New Lambton
Site Ref # / Investigator 98256, Leuven
Site Reference ID/Investigator# 427, West Heidelberg
Site Reference ID/Investigator# 337, Clayton
Site Reference ID/Investigator# 748, Diepenbeek
Site Reference ID/Investigator# 333, Liège
Site Reference ID/Investigator# 310, Brisbane
Site Reference ID/Investigator# 738, Maroochydore
Site Reference ID/Investigator# 739, Woodville
Site Reference ID/Investigator# 737, Shenton Park
Site Ref # / Investigator 95878, Gråsten
Site Reference ID/Investigator# 307, South Hobart
Site Reference ID/Investigator# 6136, Ghent
Site Reference ID/Investigator# 4631, Berlin
Site Reference ID/Investigator# 3417, Buch
Site Reference ID/Investigator# 759, Berlin
Site Reference ID/Investigator# 390, Santiago de Compostela
Site Ref # / Investigator 95719, Genoa
Site Reference ID/Investigator# 4649, Duncansville
Site Reference ID/Investigator# 316, Bethlehem
Site Reference ID/Investigator# 750, Guadalajara
Site Reference ID/Investigator# 326, Wheaton
Site Reference ID/Investigator# 319, Cumberland
Site Ref # / Investigator 95960, Hagerstown
Site Reference ID/Investigator# 488, Durham
Site Reference ID/Investigator# 1526, Madrid
Site Reference ID/Investigator# 741, Madrid
Site Reference ID/Investigator# 345, Udine
Site Reference ID/Investigator# 762, Aventura
Site Reference ID/Investigator# 325, Zephyrhills
Site Reference ID/Investigator# 327, Tampa
Site Reference ID/Investigator# 328, Sarasota
Site Reference ID/Investigator# 348, Montpellier
Site Reference ID/Investigator# 733, Rennes
Site Reference ID/Investigator# 756, Verona
Site Reference ID/Investigator# 338, Vogelsang-Gommern
Site Reference ID/Investigator# 744, Ratingen
Site Reference ID/Investigator# 749, Seville
Site Reference ID/Investigator# 314, Dayton
Site Reference ID/Investigator# 302, Rockford
Site Reference ID/Investigator# 346, Strasbourg
Site Reference ID/Investigator# 336, Lincoln
Site Reference ID/Investigator# 3415, Pierre-Bénite
Site Reference ID/Investigator# 761, Oklahoma City
Site Reference ID/Investigator# 747, Uppsala
Site Reference ID/Investigator# 2437, Dallas
Site Reference ID/Investigator# 4650, Paris
Site Reference ID/Investigator# 2532, Houston
Site Reference ID/Investigator# 758, Houston
Site Ref # / Investigator 96122, Austin
Site Reference ID/Investigator# 306, Austin
Site Reference ID/Investigator# 313, Austin
Site Reference ID/Investigator# 347, Freiburg im Breisgau
Site Reference ID/Investigator# 323, Naples
Site Reference ID/Investigator# 2500, Denver
Site Ref # / Investigator 98125, Munich
Site Reference ID/Investigator# 339, Munich
Site Reference ID/Investigator# 322, Scottsdale
Site Reference ID/Investigator# 2491, Los Angeles
Site Reference ID/Investigator# 4630, Erlangen
Site Ref # / Investigator 95957, La Jolla
Site Reference ID/Investigator# 429, La Jolla
Site Reference ID/Investigator# 3426, Piešťany
Site Reference ID/Investigator# 428, Bobigny
Site Reference ID/Investigator# 361, Lake Oswego
Site Reference ID/Investigator# 757, Eugene
Site Reference ID/Investigator# 305, Yakima
Site Reference ID/Investigator# 321, Spokane
Site Reference ID/Investigator# 2533, Worcester
Site Reference ID/Investigator# 318, Concord
Site Ref # / Investigator 98199, North York
Site Reference ID/Investigator# 4646, Edmonton
Site Reference ID/Investigator# 303, Hamilton
Site Reference ID/Investigator# 330, Hamilton
Site Reference ID/Investigator# 4634, Montreal
Site Reference ID/Investigator# 311, Montreal
Site Reference ID/Investigator# 309, Newmarket
Site Reference ID/Investigator# 304, Pointe-Claire
Site Reference ID/Investigator# 4633, Richmond
Site Reference ID/Investigator# 763, St. John's
Site Reference ID/Investigator# 4635, Toronto
Site Reference ID/Investigator# 490, Toronto
Site Reference ID/Investigator# 760, Victoria
Site Reference ID/Investigator# 4632, Winnipeg
Site Reference ID/Investigator# 754, Hradec Králové
Site Reference ID/Investigator# 332, Pilsen
Site Reference ID/Investigator# 734, Prague
Site Reference ID/Investigator# 6135, Heinola
Site Ref # / Investigator 6134, Helsinki
Site Reference ID/Investigator# 742, Görlitz
Site Reference ID/Investigator# 746, Leipzig
Site Reference ID/Investigator# 740, Cork
Site Reference ID/Investigator# 751, Dublin
Site Reference ID/Investigator# 343, Groningen
Site Reference ID/Investigator# 6133, Leiden
Site Reference ID/Investigator# 317, Maastricht
Site Reference ID/Investigator# 315, Nijmegen
Site Ref # / Investigator 95800, Oslo
Site Ref # / Investigator 95875, Oslo
Site Ref # / Investigator 96121, Alicante
Site Reference ID/Investigator# 735, Alicante
Site Reference ID/Investigator# 1525, Barcelona
Site Reference ID/Investigator# 1528, Barcelona
Site Reference ID/Investigator# 728, Stockholm
Site Reference ID/Investigator# 2565, Stockholm
Site Reference ID/Investigator# 4638, Stockholm
Site Ref # / Investigator 96126, Umeå
Site Ref # / Investigator 96120, Västerås
Site Reference ID/Investigator# 736, Västerås
Site Ref # / Investigator 96116, Bangor
Site Ref # / Investigator 95877, Cambridge
Site Ref # / Investigator 98258, Hereford
Site Ref # / Investigator 95795, Leeds
Site Ref # / Investigator 95958, London
Site Ref # / Investigator 98255, Newcastle upon Tyne
AbbVie (prior sponsor, Abbott)
INDUSTRY